GOLDMAN SACHS GROUP INC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 132 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$10,656,259
+0.7%
1,106,569
+11.3%
0.00%0.0%
Q2 2023$10,581,097
-6.6%
994,464
-7.7%
0.00%0.0%
Q1 2023$11,333,165
-10.2%
1,077,297
+5.8%
0.00%
-33.3%
Q4 2022$12,614,606
-13.6%
1,018,128
-27.7%
0.00%0.0%
Q3 2022$14,594,000
+27.6%
1,408,717
+42.0%
0.00%0.0%
Q2 2022$11,439,000
-65.3%
992,127
-62.1%
0.00%
-57.1%
Q1 2022$32,933,000
-14.7%
2,617,911
-20.9%
0.01%
-12.5%
Q4 2021$38,608,000
-3.9%
3,311,141
+7.7%
0.01%
-11.1%
Q3 2021$40,162,000
+2.9%
3,075,276
+1.4%
0.01%0.0%
Q2 2021$39,016,000
+120.7%
3,031,571
+91.7%
0.01%
+125.0%
Q1 2021$17,678,000
-28.2%
1,581,236
-26.9%
0.00%
-33.3%
Q4 2020$24,638,000
+147.3%
2,163,108
+95.3%
0.01%
+100.0%
Q3 2020$9,964,000
-16.9%
1,107,738
-4.7%
0.00%
-25.0%
Q2 2020$11,991,000
+53.7%
1,161,976
+50.3%
0.00%
+33.3%
Q1 2020$7,800,000
-56.6%
773,061
-42.7%
0.00%
-40.0%
Q4 2019$17,955,000
+102.6%
1,348,998
+30.7%
0.01%
+66.7%
Q3 2019$8,864,000
+1.1%
1,032,423
+28.9%
0.00%0.0%
Q2 2019$8,765,000
-62.0%
801,215
-53.0%
0.00%
-57.1%
Q1 2019$23,066,000
+31.1%
1,704,838
+0.4%
0.01%
+16.7%
Q4 2018$17,595,000
-19.1%
1,698,413
+44.2%
0.01%
+20.0%
Q3 2018$21,739,000
+16.9%
1,177,581
+21.1%
0.01%0.0%
Q2 2018$18,590,000
+27.7%
972,263
+3.0%
0.01%
+66.7%
Q1 2018$14,559,000
+68.7%
943,507
+63.9%
0.00%
+50.0%
Q4 2017$8,629,000
+206.0%
575,664
+221.9%
0.00%
+100.0%
Q3 2017$2,820,000
-81.3%
178,828
-77.6%
0.00%
-75.0%
Q2 2017$15,075,000
-17.9%
798,457
-25.8%
0.00%
-20.0%
Q1 2017$18,362,000
+8.2%
1,076,299
-3.0%
0.01%0.0%
Q4 2016$16,965,000
-21.2%
1,109,543
-18.2%
0.01%
-28.6%
Q3 2016$21,535,000
+347.1%
1,356,137
+268.1%
0.01%
+250.0%
Q2 2016$4,817,000
+131.4%
368,412
+93.6%
0.00%
+100.0%
Q1 2016$2,082,000
-28.3%
190,274
-24.0%
0.00%
Q4 2015$2,902,000
-24.5%
250,272
-32.1%
0.00%
-100.0%
Q3 2015$3,842,000
-59.1%
368,655
-52.6%
0.00%
-50.0%
Q2 2015$9,388,000
+62.9%
778,397
+116.2%
0.00%0.0%
Q1 2015$5,762,000
-50.3%
360,101
-52.4%
0.00%
-50.0%
Q4 2014$11,587,000
+30.5%
756,287
+10.3%
0.00%
+33.3%
Q3 2014$8,882,000
-31.9%
685,599
-19.4%
0.00%
-25.0%
Q2 2014$13,040,000
+23.0%
850,581
-1.1%
0.00%
+33.3%
Q1 2014$10,600,000
+170.5%
860,393
+155.0%
0.00%
+200.0%
Q4 2013$3,918,000
-27.1%
337,418
-25.6%
0.00%
-50.0%
Q3 2013$5,372,000
-8.9%
453,727
-23.6%
0.00%
-33.3%
Q2 2013$5,895,000
+342.9%
593,559
+394.3%
0.00%
Q4 2012$1,331,000
+137.3%
120,083
+173.3%
0.00%
Q3 2012$561,000
+102.5%
43,935
+118.5%
0.00%
Q2 2012$277,000
+8.2%
20,104
+4.7%
0.00%
Q1 2012$256,00019,2030.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$188,977,00019.02%
13D Management LLC 600,431$6,923,0003.06%
BRIDGER MANAGEMENT, LLC 956,014$11,023,0002.48%
Brown Capital Management 11,641,935$134,232,0001.80%
Price Jennifer C. 520,000$5,996,0001.02%
Monarch Partners Asset Management LLC 272,425$3,141,0000.88%
ALPHASIMPLEX GROUP, LLC 10,510$121,0000.86%
Intrinsic Value Partners, LLC 54,105$624,0000.80%
CLARK ESTATES INC/NY 355,000$4,093,0000.71%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 692$60,000,0000.63%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders